Medical tourism for aesthetic medicine in Brasília: full guide

Brasília is not the first city that comes to mind for medical tourism — and that is precisely one of its advantages. While São Paulo, Buenos Aires, and Mexico City are well-mapped on the international aesthetic circuit, Brasília occupies a distinct position: a capital city with diplomatic-grade infrastructure, a concentrated premium medical market shaped by the demands of an international resident population, and a level of discretion that high-volume tourist destinations cannot replicate.

The city's diplomatic fabric matters more than it appears to. Brasília hosts over 180 embassies and consular offices — the highest concentration in South America — and their staff represent decades of accumulated demand for international-standard healthcare delivered in English. The aesthetic medicine market in Lago Sul and the surrounding diplomatic belt has calibrated to meet that demand. Practitioners here have been treating patients with international expectations, international schedules, and international standards of follow-up for years. That is a different baseline from a medical-tourism hub that scaled quickly around volume.

The regulatory picture is equally relevant. Injectable products used at INTI clinic — Sculptra (poly-L-lactic acid), Radiesse (calcium hydroxyapatite), the Allergan and Galderma hyaluronic acid portfolios, botulinum toxin type A — are the same international formulations regulated in Europe and North America, cleared by ANVISA (Brazil's national health surveillance agency). ANVISA operates within a regulatory framework broadly aligned with FDA and CE standards for aesthetic injectables and energy-based medical devices. Patients should expect product quality parity, not a compromise.

The energy-based platforms in use at the clinic — Morpheus8 (InMode), Fotona 4D, Ultraformer MPT — are CE-marked and FDA-cleared devices distributed globally under the same manufacturer specifications. The difference from London or New York is not the equipment; it is the overhead structure, currency exchange, and market pricing — and those translate directly into a cost advantage of 40-60% for equivalent procedures.

Finally, the security profile of Brasília contrasts with the common perception of Brazil. As the federal capital and a planned city with a geographically bounded centre, Brasília has a substantially lower urban crime profile than São Paulo or Rio de Janeiro. The Lago Sul neighbourhood — where INTI clinic is located — is a residential district for senior diplomats, government officials, and executives. It reads, functionally, like an embassy compound. Patients travelling specifically for aesthetic treatment will not find themselves navigating a challenging urban environment.

The in-person visit follows a structured sequence designed to make efficient use of the patient's available time while maintaining clinical rigour at each step.

The first in-person appointment is a clinical assessment — photographic documentation, structural and anatomical mapping, and a review of the virtual consultation findings. In the majority of cases, treatment begins at this same appointment if the protocol plan is straightforward and no further tests are indicated. This compresses the timeline without compromising the clinical process: most international patients complete their first treatment on day one or two of the trip.

Post-procedure observation follows the standard windows. Most injectable and energy-based treatments produce visible oedema for 48-72 hours; this is normal and expected. Patients are advised to plan no significant commitments during this initial period. By day four or five, most patients are presentable for social or professional activities — which aligns comfortably with a five-to-seven-day trip.

Return flight aftercare. Long-haul flights introduce specific considerations for the post-procedure period. For injectable treatments, the main clinical concern is sustained pressure and immobility — relevant primarily for filler and biostimulator patients travelling within 48 hours of treatment. The standard guidance: avoid flights within 24-48 hours of filler placement where possible; for neuromodulators, the restriction is minimal (avoid vigorous head-down positions for 4 hours post-injection). Morpheus8 and laser patients should ensure the treated skin is protected from sun exposure during transit; a broad-spectrum SPF 50 and a physical sun barrier (hat, scarf) are sufficient. Cabin pressure does not materially affect the outcome of any of the procedures performed at INTI. Compression socks are recommended for any patient on a transatlantic flight, regardless of aesthetic treatment — standard deep vein thrombosis prevention during prolonged immobility.

Dr. Thiago Perfeito, CRM-DF 23199, provides a written aftercare summary in English before the patient departs. This document covers the specific post-procedure instructions for the treatments performed, the expected timeline of changes, the signs that warrant contacting the clinic, and the recommended maintenance schedule for the next 12 months. The document is formatted for sharing with a home-country practitioner or insurer if required.

Ongoing follow-up. The clinic offers teleconsultation for international patients in the weeks and months following treatment. For procedures with a progressive result timeline — biostimulators (8-12 weeks to full effect), Morpheus8 series, regenerative protocols — a teleconsultation at the 6-8 week mark allows clinical review of photographs and adjustment of the maintenance plan. Patients who return to Brasília regularly — common among diplomatic and expat communities — can structure ongoing maintenance into their visit schedule. For those who return less frequently, the protocol is designed to be sustainable with annual or biannual in-person sessions.

Updated 23 May 2026